Lipase inhibitors for the treatment of dyspepsia

Details Lipase inhibitors for the treatment of dyspepsia Lipase inhibitors for the treatment of dyspepsia

A - Human Necessities

61

K

A61K 31/365 (2006.01) A61P 1/08 (2006.01) A61P 1/14 (2006.01)

Patent

CA 2417607

The present invention refers to the use of lipase inhibitors, e.g. orlistat, for the manufacture of medicaments for treating, reducing or preventing functional dyspepsia, e.g. intensity of stomach fullness, nausea, bloating after ingestion of small or larger meal, especially of fat containing or fat rich meals, and the medicaments thus manufactured.

L'invention concerne l'utilisation d'inhibiteurs de lipase, p. ex. l'orlistat, dans la fabrication de médicaments pour traiter, réduire ou prévenir la dyspepsie fonctionnelle, p. ex. intensité de lourdeurs d'estomac, nausées, ballonnements après ingestion de petits ou de grands repas, notamment de repas contenant des graisses ou riches en graisses ; et les médicaments ainsi fabriqués.

Affiliated with

Also associated with

Rating

Lipase inhibitors for the treatment of dyspepsia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipase inhibitors for the treatment of dyspepsia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipase inhibitors for the treatment of dyspepsia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1903942